Abstract
Abstract Background Aldosterone synthase controls the synthesis of aldosterone and has been a pharmacologic target for the treatment of hypertension for several decades. Selective inhibition of ald...
Cite
CITATION STYLE
APA
Freeman, M. W., Halvorsen, Y.-D., Marshall, W., Pater, M., Isaacsohn, J., Pearce, C., … Brown, M. J. (2023). Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. New England Journal of Medicine, 388(5), 395–405. https://doi.org/10.1056/nejmoa2213169
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free